On the influence of exogeneous cyclic AMP (3',5'-adenosine monophosphate) on amyloid formation in casein-treated C3H mice.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000420:Albuterol / Q000494:pharmacology; D000682:Amyloid / Q000378:metabolism*; D000686:Amyloidosis / Q000209:etiology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002364:Caseins; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D007545:Isoproterenol / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000473:pathology; D051379:Mice; D008809:Mice, Inbred C3H; D009638:Norepinephrine / Q000494:pharmacology; D011217:Practolol / Q000494:pharmacology; D013154:Spleen / Q000187:drug effects / Q000473:pathology; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000682:Amyloid; D002364:Caseins; D003983:Dibenzylchlorethamine; D003994:Bucladesine; D013806:Theophylline; D007545:Isoproterenol; D000420:Albuterol; D011217:Practolol; D009638:Norepinephrine; D004837:Epinephrine